[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] [0.03%]
[心脏淀粉样变性患者诊断治疗路径——SIC/ANMCO共识文件。由意大利心脏淀粉样变性网络（RIAC）编辑]
Aldostefano Porcari,Cristina Chimenti,Marco Merlo et al.
Aldostefano Porcari et al.
The perspective on cardiac amyloidosis has deeply changed over the last 10 years following major advances in diagnosis and treatment options. This heterogeneous disease requires the interaction among experts of different specialties and sub...
Practice Guideline
Giornale italiano di cardiologia (2006). 2024 Dec;25(12):900-920. DOI:10.1714/4372.43703 2024
[ANMCO Statement: semaglutide in cardio-nephro-metabolic disorders] [0.03%]
[ANMCO声明：司美格鲁肽在心血管-肾脏-代谢性疾病中的应用]
Leonardo De Luca,Claudio Bilato,Alessandro Navazio et al.
Leonardo De Luca et al.
Semaglutide, a glucagon-like peptide-1 receptor agonist, has emerged as a pivotal therapeutic agent in the management of the cardio-renal-metabolic continuum. Initially developed for glycemic control in type 2 diabetes mellitus, its benefit...
[Intermediate-high risk pulmonary embolism: time matters. The case of a young breastfeeding woman] [0.03%]
[中高危肺栓塞：时间是关键。一名年轻哺乳期女性的病例]
Marco Giovanni Mennuni,Leonardo Grisafi,Martina Solli et al.
Marco Giovanni Mennuni et al.
Pulmonary embolism in the post-partum period is a critical condition with significant implications for maternal and infant health. We present a case report illustrating the challenges in the clinical management of a patient with intermediat...
Luca Bergamasco,Stefano Maffè,Paola Paffoni et al.
Luca Bergamasco et al.
A 38-year-old man was evaluated for heart palpitations and chest pain diagnosed with atrial fibrillation, left ventricular ejection fraction 30%, and moderate aortic insufficiency. On echocardiographic control, evidence of aortic bicuspid v...
[Sodium-glucose cotransporter 2 inhibitors in acute heart failure: the EMPULSE trial and literature review] [0.03%]
钠-葡萄糖协同转运蛋白2抑制剂在急性心力衰竭中的应用：EMPULSE试验及文献回顾
Stefania Angela Di Fusco,Andrea Matteucci,Antonella Spinelli et al.
Stefania Angela Di Fusco et al.
In heart failure management, hospitalization is the main cause of medical costs and is associated with an increased risk of adverse events. This review reports evidence on hospitalization as the ideal setting for disease-modifying therapy i...
[Dilation of the ascending aorta: diagnosis, clinical presentation, and indication for surgery. The crucial role of the cardiologist] [0.03%]
升主动脉扩张的诊断、临床表现及手术指征——心脏病专家的关键作用
Susanna Grego,Alberto Pozzoli,Stefanos Demertzis
Susanna Grego
The diagnosis of ascending aortic aneurysm, its precise assessment criteria and indications for surgery represent a chapter of great stimulus and interest for the clinical cardiologist. There are many factors influencing the classification ...
[An ECG in times of crisis] [0.03%]
[形势下的心电图]
Lorenzo Spighi,Samuela Carigi,Filippo Ottani
Lorenzo Spighi
[Vutrisiran: a new therapeutic option for cardiac transthyretin amyloidosis] [0.03%]
[外用vutrisiran：心脏转甲状腺素蛋白淀粉样变性新疗法]
Giorgia Panichella,Alberto Aimo
Giorgia Panichella
[2024 European guidelines for aortic disease: ESC versus EACTS/STS] [0.03%]
[2024年欧洲主动脉疾病指南：ESC vs EACTS/STS]
Luca Di Marco,Davide Pacini
Luca Di Marco
[European guidelines for the management of peripheral arterial and aortic diseases: what's new?] [0.03%]
欧洲外周动脉和主动脉疾病治疗指南更新了哪些内容？
Marco Marini,Eugenio Stabile
Marco Marini